RLMD
NASDAQ HealthcareRelmada Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $6.15 |
|---|---|
| Volume | 1,353,517 |
| Market Cap | 451.00M |
| Beta | 0.730 |
| RSI (14-Day) | 68.8 |
| 200-Day MA | $2.50 |
| 50-Day MA | $4.32 |
| 52-Week High | $7.51 |
| 52-Week Low | $0.24 |
| Forward P/E | -17.08 |
| Price / Book | 21.58 |
🎯 Investment Strategy Scores
How RLMD scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
40/100
High dividend yield + low volatility
🚀 Moon Shot
14/100
High growth potential (high beta + oversold)
🔪 Falling Knife
1/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
93/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
11/100
Large-cap, institutional-quality stocks
Find RLMD in your text
Paste any text on the homepage — the tool will extract RLMD and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.